Sol-Gel Technologies (SLGL) Competitors $6.90 -0.17 (-2.39%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. SNTI, UNCY, CLYM, STRO, EPIX, PYXS, ADAP, IGMS, TNYA, and IMMXShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Senti Biosciences (SNTI), Unicycive Therapeutics (UNCY), Climb Bio (CLYM), Sutro Biopharma (STRO), ESSA Pharma (EPIX), Pyxis Oncology (PYXS), Adaptimmune Therapeutics (ADAP), IGM Biosciences (IGMS), Tenaya Therapeutics (TNYA), and Immix Biopharma (IMMX). These companies are all part of the "pharmaceutical products" industry. Sol-Gel Technologies vs. Senti Biosciences Unicycive Therapeutics Climb Bio Sutro Biopharma ESSA Pharma Pyxis Oncology Adaptimmune Therapeutics IGM Biosciences Tenaya Therapeutics Immix Biopharma Sol-Gel Technologies (NASDAQ:SLGL) and Senti Biosciences (NASDAQ:SNTI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Does the MarketBeat Community believe in SLGL or SNTI? Sol-Gel Technologies received 143 more outperform votes than Senti Biosciences when rated by MarketBeat users. Likewise, 63.40% of users gave Sol-Gel Technologies an outperform vote while only 50.00% of users gave Senti Biosciences an outperform vote. CompanyUnderperformOutperformSol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Senti BiosciencesOutperform Votes650.00% Underperform Votes650.00% Which has higher earnings & valuation, SLGL or SNTI? Sol-Gel Technologies has higher revenue and earnings than Senti Biosciences. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$12.10M1.61-$27.24M-$4.70-1.48Senti Biosciences$2.56M31.48-$71.06M-$10.84-0.29 Do analysts recommend SLGL or SNTI? Sol-Gel Technologies currently has a consensus price target of $40.00, suggesting a potential upside of 473.48%. Senti Biosciences has a consensus price target of $8.50, suggesting a potential upside of 175.08%. Given Sol-Gel Technologies' higher probable upside, research analysts clearly believe Sol-Gel Technologies is more favorable than Senti Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor SLGL or SNTI? In the previous week, Senti Biosciences had 7 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 8 mentions for Senti Biosciences and 1 mentions for Sol-Gel Technologies. Senti Biosciences' average media sentiment score of 0.14 beat Sol-Gel Technologies' score of -1.00 indicating that Senti Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Sol-Gel Technologies Negative Senti Biosciences Neutral Which has more volatility and risk, SLGL or SNTI? Sol-Gel Technologies has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Senti Biosciences has a beta of 2.23, indicating that its stock price is 123% more volatile than the S&P 500. Is SLGL or SNTI more profitable? Senti Biosciences has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-81.75% -27.17% -22.49% Senti Biosciences N/A -154.84%-77.42% Do insiders & institutionals have more ownership in SLGL or SNTI? 26.2% of Sol-Gel Technologies shares are owned by institutional investors. Comparatively, 25.7% of Senti Biosciences shares are owned by institutional investors. 66.5% of Sol-Gel Technologies shares are owned by insiders. Comparatively, 3.1% of Senti Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummarySol-Gel Technologies beats Senti Biosciences on 10 of the 17 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.43M$6.85B$5.57B$8.66BDividend YieldN/A2.50%5.27%4.19%P/E Ratio-20.518.8827.3420.20Price / Sales1.61267.20415.29164.38Price / CashN/A65.8538.2534.64Price / Book4.186.727.174.73Net Income-$27.24M$143.74M$3.23B$248.00M7 Day Performance-5.11%12.24%6.74%4.53%1 Month Performance-11.15%21.46%15.54%10.88%1 Year Performance-9.42%9.88%32.85%15.20% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies1.7034 of 5 stars$6.91-2.3%$40.00+478.9%-13.1%$19.25M$12.10M-20.3250Negative NewsSNTISenti Biosciences2.8939 of 5 stars$3.09-1.6%$12.00+288.3%+11.2%$80.59M$2.56M-0.204UNCYUnicycive Therapeutics3.6579 of 5 stars$0.66+13.1%$6.00+805.8%+16.0%$79.91M$680,000.00-0.689News CoveragePositive NewsGap DownCLYMClimb Bio3.0316 of 5 stars$1.18flat$8.50+620.3%N/A$79.74MN/A-0.559STROSutro Biopharma4.3546 of 5 stars$0.90+0.8%$6.11+575.8%-77.7%$76.42M$66.43M-0.56240Positive NewsEPIXESSA Pharma1.9689 of 5 stars$1.71+1.8%$2.00+17.0%-70.3%$75.91MN/A-2.4850Positive NewsPYXSPyxis Oncology1.9556 of 5 stars$1.22+0.8%$9.00+637.7%-64.5%$75.58M$16.15M-1.1860ADAPAdaptimmune Therapeutics2.9119 of 5 stars$0.28-2.6%$1.52+432.9%-72.4%$75.51M$179.64M-1.30490IGMSIGM Biosciences4.0244 of 5 stars$1.26-0.8%$5.50+336.5%-84.3%$75.32M$2.68M-0.35190Analyst DowngradeTNYATenaya Therapeutics3.5886 of 5 stars$0.46flat$6.25+1,258.7%-81.2%$74.83MN/A-0.32110Positive NewsGap UpIMMXImmix Biopharma2.8072 of 5 stars$2.60+11.1%$7.00+169.2%+15.3%$72.48MN/A-3.069High Trading Volume Related Companies and Tools Related Companies Senti Biosciences Alternatives Unicycive Therapeutics Alternatives Climb Bio Alternatives Sutro Biopharma Alternatives ESSA Pharma Alternatives Pyxis Oncology Alternatives Adaptimmune Therapeutics Alternatives IGM Biosciences Alternatives Tenaya Therapeutics Alternatives Immix Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLGL Stock Free SLGL Stock Alerts